Inhibition of tumor induction in two-stage carcinogenesis on mouse skin.
D000348:Aflatoxins / Q000008:administration & dosage; D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001551:Benz(a)Anthracenes; D002738:Chloroquine / Q000008:administration & dosage; D003510:Cyclohexanes / Q000008:administration & dosage; D003561:Cytarabine / Q000008:administration & dosage; D003609:Dactinomycin / Q000008:administration & dosage; D004988:Ethers, Cyclic / Q000008:administration & dosage; D005260:Female; D051379:Mice; D009374:Neoplasms, Experimental; D012878:Skin Neoplasms / Q000188:drug therapy*; D014498:Uracil / Q000008:administration & dosage
D000348:Aflatoxins; D000970:Antineoplastic Agents; D001551:Benz(a)Anthracenes; D003510:Cyclohexanes; D004988:Ethers, Cyclic; D003561:Cytarabine; D003609:Dactinomycin; D014498:Uracil; D002738:Chloroquine